chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Bad flu like symptoms; This case was reported by a other health professional via sales rep and described the occurrence of influenza-like symptoms in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient stated that had very bad flu like symptoms after vaccination. The symptoms resolved within two to three days and the patient plans to still get their second dose. The representative has no further details to provide. The Follow up not required.
27mar90 pt vax hepta B. 17apr90 pt devel sharp pain in left arm which radiated from her shoulder to elbow.  27apr90 2nd vax. sx reccured. pt recv 3rd vax and felt achiness in both arms and shoulders.
During first week experienced episodes of rapid heart beat randomly. 1 week post injection developed a hard ball with small scab. Scab/ball expressed small amount of blood and began weeping. Covered with a band aid over night. Skin in area became raised and red. Appeared to have burned and developed a scab about the size of a quarter. Slow to heal; scabbed for 2 weeks. Scab came off leaving the area red a raw. Very irritated with itching, intense at times. Week 3 remains raised and red. Improved with OTC Hydrocortisone, but sites remains with itching. Appears to be scaring.
Soreness in arm 4 months out from vaccination date; Was too sick after shot to work for 2 days.; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "known allergies: dairy" (unspecified if ongoing); "COVID prior vaccination" (unspecified if ongoing). There were no concomitant medications. Vaccination history included: Comirnaty (First dose, MANUFACTURER UNKNOWN, vaccine location: Right arm), for COVID-19 immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 21Oct2021, outcome "recovered with sequelae", described as "Soreness in arm 4 months out from vaccination date"; ILLNESS (non-serious) with onset 21Oct2021, outcome "recovered with sequelae", described as "Was too sick after shot to work for 2 days.". Therapeutic measures were not taken as a result of pain in extremity, illness. Additional information: no other vaccine in four weeks and no other medications in two weeks.   The lot number for bnt162b2 was not provided and will be requested during follow up.
COVID AFTER VACCINATION; This spontaneous report received from a parent concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch number. No concomitant medications were reported. On an unspecified date, the patient experienced covid after vaccination. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of covid after vaccination was not reported. This report was non-serious. This case, from the same reporter is linked to 20211212211.
I vomited multiple times over the course of a couple days and I had a fever of 101 with lots of sore muscles
Chills; Headache; This is a spontaneous report from a contactable physician via Pfizer sales representative. A patient of unspecified age and gender received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (PREVNAR 13), via an unspecified route of administration on an unspecified date at a single dose for immunisation. The patient's medical history and concomitant medications were not reported. Patient was described to have gotten chills and a headache after receiving the vaccine. Outcome of the events was unknown.   Information on the lot/batch number has been requested.
Onset w/ myalgias, back pain and severe headache.  Next day with  swelling and shooting pain in Right  arm (Injection was given in Left arm) Shooting pains in bilateral thighs. Migrating polyarthralgia, bilateral hand tingling.  Debilitating pain and fatigue that is interfering with activities of daily living including employment
This case was reported by a nurse via call center representative and described the occurrence of anaphylaxis in a 57-year-old patient who received DTaP vaccine for prophylaxis. On an unknown date, the patient received DTaP vaccine at an unknown dose. On an unknown date, unknown after receiving DTaP vaccine, the patient experienced anaphylaxis (serious criteria GSK medically significant). On an unknown date, the outcome of the anaphylaxis was unknown. It was unknown if the reporter considered the anaphylaxis to be related to DTaP vaccine. Additional details were provided as follows: The case was received via Webform. The age at the vaccination was not reported. The patient was 57 years old at the reporting time. The health care professional stated that she had a patient who had a history of severe anaphylaxis to Tdap. It was unsure if vaccine was BOOSTRIX or another TDaP.
broke out; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 41 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12Oct2021 13:15 (Lot number: FF8841, Expiration Date: 31Dec2021) at the age of 41 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "covid-19" (unspecified if ongoing), notes: caught covid before and wanted to make sure. The patient took concomitant medications. Vaccination history included: Bnt162b2 (1st dose, lot EW0182, NDC unknown, expiration date 30Nov2021.), administration date: 21Sep2021, when the patient was 41 years old, for COVID-19 Immunization. The following information was reported: RASH (non-serious) with onset 14Oct2021, outcome "not recovered", described as "broke out".  Additional information: Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.  No follow-up attempts are possible. No further information is expected.
Pt recvd 2 doses of hep B vax & devel urticaria & allergy to seafood p/ 2nd dose.Tx w/ Seldane.
Patient stated extreme anxiety of needles and history of syncope post-vaccination. He tensed up immediately prior to vaccination. After administration, patient got light headed lost consciousness (syncope) for about 20-30 seconds before becoming alert again. He brought someone else with him to the vaccination, and she helped keep him seated until he was aware again. He remained light headed for a few minutes afterward, so he remained in the booth for about 25 minutes and drank some pop and had a snack.
High fever 102, pain in center of chest, Doctor said to take aleve which stopped the pain in the chest, next day I got Afib and they put me on blood thinner. The Afib went away after a week on and off. still on blood thinner to be safe. Also I got a flu shot at the same time
I developed a slight headache and soreness in arm after vaccine. Approx. around 7pm I had a throbbing pain in my right upper front and back shoulder as well as under my arm. This throbbing did not let up. My lymph node seemed to be inflamed. I called the clinic I received the shot the next  morning and they told me they had not rec'd any complaints of adverse effects like this. I was informed I might want to call my doctor. I got worked in at the doctors office on 7/12/19. My lymph node was slightly enlarged and very tender to palpation. The NP I saw, said that because it was in the localized area of the shot, she would say it was just my body's adverse reaction to the shot. I was told to take ibuprofen and ice it down and if better by Monday, it was probably the shot. If not better, come back to office for further testing.  By Monday morning, it was a lot better and not near as tender or painful. The lymph node was so inflamed I couldn't stand to wear a bra or put my arm down. Felt a lot better in cool water and with ice. No problems now. I was told that I might want to report this so if anyone else had a reaction this way, it would be logged.
I felt very sick the next day. I felt like I was going to throw up then I passed out.
Participant sitting in Vaccination monitoring area; est. 10 min post first dose Pfizer vaccination (Lot# ER 8733). Participant's mother voiced "son c/o feeling lightheaded." 1552 Assessed while sitting and participant is clammy, pale with c/o of feeling faint and stomach bothering him". 1555 Noted allergy of PCN with medical hx of reflux, autism and some anxiousness per mother; Attempted to moved to monitoring cot but participant voiced inability to stand up. 1557 EMS called to site. 1559 BP 118/72, P 90, O2 sat 98%; sitting. 1602 Participant provided sips of H2O; swallows without diff. Skin remains clammy / pale with no resp distress; O2 sat 99% / P 70. 1604 BP 124/68 - P 70 - Sat 99% with decrease paleness. 1605 Fire Rescue team arrives. Participant voiced "Feeling better with no feeling of faintness / lightheadedness". Noted decrease in clamminess. 1607 Mom remains at participant side and voiced son "son looks / feels better. 1608 P - 64, O2 SAT 99% with participant requesting to stand up at time. 1611 Paramedics arrived with assessment of participant. 1615 Participant ambulated on his own without difficulty; paramedics monitoring. 1618 Participant's mother declines EMS transport for further evaluation; will transport participant back home and monitor. At time EMS provided education on s/s monitoring and 911 follow up then departed scene. 1821 Participant and mother denies any continued complaints; noted pink / dry skin / P 70 / Sat 98%. Participant voiced he's "just hungry now"; mother shared both will stop and eat before traveling home. 1621 Discharged from site - mother and participant ambulated to private car with assist of Nurse without c/o or incident. Reminded to eat, drink and let PCP know about events post vaccination. *Vaccine exp. date 7/2021
Submitting out of an abundance of caution. PT requested flu and Tdap immunizations at our location.  After verifying the vaccinations to be administered with PT, HD Fluzone was given in the left arm.  PT pulled sleeve up on right arm for Tdap to be given when a band-aid was noticed.  Upon questioning PT did not know what it was from, only then did she remember she'd gotten a flu shot earlier in the day from her PCP.  PT was given Tdap more than 1 inch from prior flu shot and asked to wait in the waiting area to be sure she had no adverse reaction.
Histamine reaction: red, hot sweaty cheeks that became a little puffy; slightly itchy lips; red splotchy patches on parts of my legs, chest, feet (mostly toes), and hands (mostly  fingers). Started with my cheeks within minutes of the shot, got worse over the next hour. It took about 4-5 hours to dissipate. But even the next day, I have been a little itchy.
After the first vaccine she experienced pain in arm and pain between the eyes. She also had flu like symptoms for approximately 3 days, and unusual bowel movements not diarrhea, not constipated, but not normal and painful.  After second dose had similar reaction bowel issues are still bad and very painful (to the point of vomiting during bowel movements  due to pain). She saw her primary care doctor and was Rx'd a cream.  This has caused her to decrease her eating.  This did not help and she was having loss of visual acuity and started not being able to speak properly so went to the ED  for concern over Strokes.     had 2 MRIs, and determined not to be having a stroke so was released to home.  Sxs seemed to resolve ( like a spell) .   Was still having bowel issues and she also developed a rash from the neck to the groin. So she went to a specialist.   The Rash cleared after about 3 days.   Specialist advised that the sxs were all due to the COVID Vaccine.  Flank pain under the right ribs has also been present, this is not improving,  it is a dull pain that seems to be worsening  ( the bowel seems to be about back to normal now) She is planning on speaking with her PCP about the right flank pain.
This spontaneous report as received from a nurse refers to an unspecified patients of unknown age and gender. On an unknown date, patients were vaccinated with improperly stored M-M-R II (dose, frequency, route of administration and indication were not provided). No concomitants were reported. No adverse events were reported. The outcome of events was unknown. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Patient was monitored for >15 minutes after vaccination. Patient told a nurse that her knees felt weak. Patient then fainted and was laying on the floor when i arrived. Patient reported she felt like she was "floating" and she did not want to "fall". She was also nausea and wanted to vomit and did not end up vomiting anything up. Patient fainted several more times. Her BP was around 143/80 and unsure about the pulse. Patient then become unresponsive for 20-30 seconds.
A few days after getting my second dose I started feeling something wrong with my face. The muscles in my face feel droopy. The next day face started drooping more, and twitching. I went to the ER Sunday morning; they did blood work. When the results came back, they said I would have a long recovery and I had Bell's Palsy. I asked the Dr. If it was in relation to the vaccine but he did not confirm or deny that it was. Since I have diabetes, that could be a reaction but did not want to say if it was or not. The droopiness has stopped but still now the doctor has said my eye has been different since then.
This spontaneous report as received from a Registered Nurse refers to multiple patients of unknown age and gender. No medical history and concurrent conditions were reported. On an unknown date, the patients were vaccinated with VAQTA, lot # N008823, expiry date: 26-MAY-2018 for prophylaxis. Dosing details and route of administration were not reported. No concomitant medications were reported. No adverse effects were reported. On an unknown date, the vaccine was exposed to temperature of -1°C or colder (-1°C) for 11 hours 29 minutes. No previous temperature excursion were reported. This case was reported because of a data logger. No product quality complaint (PQC) was reported. No further information was provided. This is one of several reports received from the same reporter; Sender's Comments: US-009507513-1708USA006090: US-009507513-1708USA006089: US-009507513-1708USA005593: US-009507513-1708USA006088:
Shortly after receiving the vaccine, the patient felt like her throat was swollen and her heart was racing.  Her blood pressure was taken in the observation area, and it was elevated.  She was monitored in the observation area, and then she was escorted to the Emergency Department for continued observation.   Reaction resolved with no treatment while she was in the Emergency Department and she was discharged.  She was instructed to follow up with her allergist.
On Saturday the 23rd I took the shot, around midnight or 1:00 am. From that point on I do not recall anything. The next time I have any memory of anything is Friday morning at 1 or 2 am. I am trying to remember how to use my eye drops (for glaucoma) and I am trying to remember my dogs name. My wife said I was acting strangely because I was trying to use my eye drops but I didn't have any eye drops in my hand. I woke her up and she was trying to figure out what I was doing. No memory from  1 or 2 am on Sunday until early Friday morning.  I did not see my doctor but will be contacting my doctor to see if I can be seen.
Pt vaccinated with Pneumovax 23 developed a red, hot swollen arm w/lymphangitis & swollen glands. Treated with Cefazolin sodium.
Redness, swelling, warmth and itch on injection site; Redness, swelling, warmth and itch on injection site; Redness, swelling, warmth and itch on injection site; Redness, swelling, warmth and itch on injection site; This spontaneous case was received on 22-Oct-2020 from other health professional (nurse) via Med Communications (reference number: SEQW20-04125) and concerned a 51-year-old female patient.  The patient had no relevant medical history and was not taking any concomitant medications.  On 15-Oct-2020, the patient was vaccinated with Flucelvax QIV (influenza vaccine, subunit influenza virus vaccine polyvalent; dose: 0.5 ml, route of administration: intramuscular and anatomical location: deltoid) for influenza prophylaxis. The batch number was 283847 and expiry date 30-Jun-2021.   On the same day, after receiving Flucelvax QIV, the patient experienced redness, swelling, warmth, and severe itch on injection site. The patient did not receive any treatment for the events.  On 18-Oct-2020, the patient recovered from all the events.  The reporter did not provide a causality assessment to Flucelvax QIV.  The reporter assessed all the events as non-serious.  This case is linked to cases 202005407, 202005408, and 202005409, 202005411 due to the same reporter.  Company comment:The patient developed vaccination site warmth, vaccination site pruritus, vaccination site swelling and vaccination site erythema on the same day after vaccination with the suspect product, Flucelvax QIV. Chronology is suggestive. Reportedly, the patient had no relevant medical history and was not taking any concomitant medications. Considering all above mentioned, causal relationship for all events is assessed as possibly related. (defaults to ''related'' in the safety database for reporting purposes).; Sender's Comments: The patient developed vaccination site warmth, vaccination site pruritus, vaccination site swelling and vaccination site erythema on the same day after vaccination with the suspect product, Flucelvax QIV. Chronology is suggestive. Reportedly, the patient had no relevant medical history and was not taking any concomitant medications. Considering all above mentioned, causal relationship for all events is assessed as possibly related. (defaults to ''related'' in the safety database for reporting purposes).
Burning sensation in arm. Took pain meds to stop the pain with headache. Next morning, felt like the Flu. Bad headache, extremely tired. The burning was all the way into her arm. Will not have the second dose.
Pulmonary embolism diagnosed via CT scan chest on 04/15/2021.
myalgias 31May2022; fevers 01Jun; cough; Rhinorrhea; HA; This is a spontaneous report received from a non-contactable reporter(s) (Nurse).  A 60-year-old male patient received BNT162b2 (BNT162B2), on 08Apr2022 as dose 4 (booster), single (Lot number: FL3197) at the age of 60 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (prev dose product: COVID 19, prev dose brand: Pfizer, prev dose brand unknown: False, prev dose lot number: EL3247, prev dose lot unknown: False, prev dose administration date: 17Mar2021 prev dose dose number: 2), administration date: 17Mar2021, when the patient was 59-year-old, for Covid-19 immunization; BNT162b2 (prev dose product: COVID 19, prev dose brand: Pfizer, prev dose brand unknown: False, prev dose lot number: EL3247, prev dose lot unknown: False, prev dose administration date: 23Feb2021 prev dose dose number: 1), administration date: 23Feb2021, when the patient was 59-year-old, for Covid-19 immunization; Covid-19 vaccine (prev dose product: COVID 19, prev dose brand unknown: True, prev dose brand name unknown: COVID19 Vaccine, prev dose lot unknown: True, prev dose lot unknown reason: Not available/provided to reporter at the time of report completion, prev dose dose number: 3), for Covid-19 immunization. The following information was reported: HEADACHE (non-serious) with onset 31May2022, outcome "unknown", described as "HA"; RHINORRHOEA (non-serious) with onset 31May2022, outcome "unknown", described as "Rhinorrhea"; COUGH (non-serious) with onset 31May2022, outcome "unknown"; PYREXIA (non-serious) with onset 31May2022, outcome "unknown", described as "fevers 01Jun"; MYALGIA (non-serious) with onset 31May2022, outcome "unknown", described as "myalgias 31May2022". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of myalgia, pyrexia, cough, rhinorrhoea, headache.  Additional information: Patient took Paxlovid  for the adverse events of myalgia, pyrexia, cough, rhinorrhoea, headache. Patient did not have covid prior vaccination. Patient had a positive nasal swab covid test post vaccination.  No follow-up attempts are possible. No further information is expected.
Based on phone call from patient around 1:15pm 9/4/17: Very severe pain in arm at injection site, swelling/inflammation at injection site, jaw on left side was stiff upon awakening this morning after vaccination making it difficult to talk, patient having hot flashes and a lot of anxiety regarding reaction. He wanted to see his PCP to address, but office closed for labor day; the on-call provider recommended he go to the ER. Patient decided to go to ER as he was nervous that the reaction was going to continue to get worse, but wanted the pharmacy to be informed and to be reassured that he received Flu vaccine, as he never had issues in the past.
Information has been received from a physician concerning a patient who was subcutaneously vaccinated with a 0.65 ml dose of ZOSTAVAX (Merck) two weeks ago (on 31-MAR-2009). Subsequently, the patient developed shingles after having received ZOSTAVAX (Merck) on an unspecified date. The patient sought unspecified medical attention. Additional information has been requested.
headache and URI symptoms that had started suddenly and been persistent.  She complains of worsening sinus pressure and congestion now with cough though denies chest pain, shortness of breath, or wheezing.
From correspondence received on 10/26/01,it was reported that a 49 year old female patient received a Fluzone vaccination on 10/18/01. The patient stated "bad smelling odor" at the injection site - no odor detected by physician.
Patient received first dose of H1N1 vacciine on 11/05/2009 and second on 12/02/2009.